Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02896036 · ClinicalTrials.gov registry record · NA
Veress Entry With/Without Concomitant CO2
A NA study, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02896036: Completed NA study, sponsored by University of South Florida.
NCT02896036 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02896036, a NA study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Purpose: The primary objective is to compare the time required for adequate intraperitoneal insufflation (from skin incision to reaching intraperitoneal pressure of 15 mmHg). Also the number of attempts needed before successful entry is achieved. The secondary objectives will evaluate rates of secondary outcomes measures such as; failed entry, extra peritoneal insufflation, vascular injury, visceral injury, gas embolism, solid organ injury, and omental injury between the two techniques. Study design: prospective randomized control trial Hypothesis: The investigators hypothesize that participant's undergoing laparoscopic surgery for benign Gynecologic indications at TGH who undergo laparoscopic entry technique of Veress needle entry with concomitant CO2 insufflation will require less time to achieve a 15 mmHg of intraperitoneal pressure as opposed to Veress needle entry with subsequent CO2 insufflation, and will require less number of attempts to achieve successful entry.
Primary Outcome
Time from insertion of Veress to insufflation of peritoneum to 15 mmHg.
Interventions
- PROCEDURE Veress needle entry with concomitant CO2
- PROCEDURE Veress needle entry with subsequent CO2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-03-10 |
| Phase | NA |
What the finished NCT02896036 record still lists
NCT02896036 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Veress needle entry with concomitant CO2 is the first listed.
NCT02896036 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02896036 about?
NCT02896036 is a clinical study titled "Veress Entry With/Without Concomitant CO2". Purpose: The primary objective is to compare the time required for adequate intraperitoneal insufflation (from skin incision to reaching intraperitoneal pressure of 15 mmHg). Also the number of attempts needed before successful entry is achieved. The secondary objectives will evaluate rates of secon...
What is the current status of trial NCT02896036?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2016-08. Estimated completion is 2018-03-10.
What interventions are being tested in trial NCT02896036?
The interventions under investigation include: Veress needle entry with concomitant CO2 (PROCEDURE), Veress needle entry with subsequent CO2 (PROCEDURE).
Who is sponsoring clinical trial NCT02896036?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02896036's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia